News | March 20, 2024
AstraZeneca buys biopharmaceutical company Fusion
To accelerate the development of next-generation radioconjugates to treat cancer
To accelerate the development of next-generation radioconjugates to treat cancer
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Cureskin aims to disrupt the large and growing skin and hair care industry in India
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
The launch of a DGCA Type Approved Logistics Drone facilitates critical medical deliveries to remote regions
Subscribe To Our Newsletter & Stay Updated
